Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piero Vernia

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|September 7, 2010
Leukocytapheresis in the treatment of inflammatory bowel disease: Current position and perspectivesPiero Vernia, Valeria D'Ovidio, Donatella Meo
Rheumatology International|June 25, 2009
Successful resolution of pneumonia developed in a patient affected by Crohn's disease, rheumatoid arthritis, myasthenia gravis and recurrent uveitis during concomitant treatment with tumour necrosis factor alpha inhibitors and conventional immunosuppressive drugsErika Angelucci, Monica Cesarini, Piero Vernia
Journal of Crohn'S & Colitis|November 26, 2011
Guillain-Barrè syndrome after treatment with human anti-tumor necrosis factorα (adalimumab) in a Crohn's disease patient: case report and literature reviewMonica Cesarini, Erika Angelucci, Tiziana Foglietta, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 9, 2016
Short term colectomy rate and mortality for severe ulcerative colitis in the last 40 years. Has something changed?Valeria Clemente, Annalisa Aratari, Claudio Papi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 2, 2020
Early hydrogen excretion peaks during breath tests. Small intestinal bacterial overgrowth or accelerated transit?Piero Vernia, Monica Cesarini, Aurora de Carolis, et al.
Inflammatory Bowel Diseases|March 28, 2007
Another paradox in Crohn's disease: new onset of psoriasis in a patient receiving tumor necrosis factor-alpha antagonistErika Angelucci, Andrea Cocco, Angelo Viscido, et al.
Clinical Nutrition (Edinburgh, Scotland)|September 24, 2004
Self-reported milk intolerance in irritable bowel syndrome: what should we believe?Piero Vernia, Vanessa Marinaro, Fiorenza Argnani, et al.
Journal of Clinical Apheresis|September 3, 2014
Ulcerative colitis and granulocyte-monocyte-apheresis: safety and efficacy of maintenance therapy during pregnancyValeria D'Ovidio, Donatella Meo, Maria Gozer, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|April 13, 2006
Hydrogen breath test for diagnosis of lactose malabsorption: the importance of timing and the number of breath samplesMauro Di Camillo, Vanessa Marinaro, Fiorenza Argnani, et al.
European Journal of Gastroenterology & Hepatology|September 9, 2005
Is Cronkhite-Canada Syndrome necessarily a late-onset disease?Piero Vernia, Adriana Marcheggiano, Vanessa Marinaro, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|September 7, 2010
Leukocytapheresis in the treatment of inflammatory bowel disease: Current position and perspectivesPiero Vernia, Valeria D'Ovidio, Donatella Meo
Rheumatology International|June 25, 2009
Successful resolution of pneumonia developed in a patient affected by Crohn's disease, rheumatoid arthritis, myasthenia gravis and recurrent uveitis during concomitant treatment with tumour necrosis factor alpha inhibitors and conventional immunosuppressive drugsErika Angelucci, Monica Cesarini, Piero Vernia
Journal of Crohn'S & Colitis|November 26, 2011
Guillain-Barrè syndrome after treatment with human anti-tumor necrosis factorα (adalimumab) in a Crohn's disease patient: case report and literature reviewMonica Cesarini, Erika Angelucci, Tiziana Foglietta, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 9, 2016
Short term colectomy rate and mortality for severe ulcerative colitis in the last 40 years. Has something changed?Valeria Clemente, Annalisa Aratari, Claudio Papi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 2, 2020
Early hydrogen excretion peaks during breath tests. Small intestinal bacterial overgrowth or accelerated transit?Piero Vernia, Monica Cesarini, Aurora de Carolis, et al.
Inflammatory Bowel Diseases|March 28, 2007
Another paradox in Crohn's disease: new onset of psoriasis in a patient receiving tumor necrosis factor-alpha antagonistErika Angelucci, Andrea Cocco, Angelo Viscido, et al.
Clinical Nutrition (Edinburgh, Scotland)|September 24, 2004
Self-reported milk intolerance in irritable bowel syndrome: what should we believe?Piero Vernia, Vanessa Marinaro, Fiorenza Argnani, et al.
Journal of Clinical Apheresis|September 3, 2014
Ulcerative colitis and granulocyte-monocyte-apheresis: safety and efficacy of maintenance therapy during pregnancyValeria D'Ovidio, Donatella Meo, Maria Gozer, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|April 13, 2006
Hydrogen breath test for diagnosis of lactose malabsorption: the importance of timing and the number of breath samplesMauro Di Camillo, Vanessa Marinaro, Fiorenza Argnani, et al.
European Journal of Gastroenterology & Hepatology|September 9, 2005
Is Cronkhite-Canada Syndrome necessarily a late-onset disease?Piero Vernia, Adriana Marcheggiano, Vanessa Marinaro, et al.
Pageof 4